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The common use of non-traditional therapies has prompted the demand for more clear understanding of mechanism of 
action, performance of clinical trials and good manufacturing practices.
In this supplement, Hochberg provides information on several commonly used practices, such as acupuncture and herbal 
preparations. Kharazmi then summarizes the potential mechanisms of action of a speciﬁ c herbal product in use for several 
years in Europe - rosehip. He demonstrates a speciﬁ c fraction of the rosehip has anti-inﬂ ammatory properties. Winther then 
summarizes clinical trials testing the rosehip product and contrasts results with glucosamine and chondroitin sulfate. Finally,
I summarize the state of complimentary and alternative medicine from the federal, patient and physician perspective.
This supplement adds information on the continued use and apparently increasing use in osteoarthritis for non-traditional 
therapies, particularly herbal products. Increasing clinical trial data are needed for most of these products. The rosehip has 
shown some potential as a therapeutic agent.
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